AMSTERDAM and WASHINGTON, Oct. 26,
2016 /PRNewswire/ -- Royal Philips (NYSE: PHG AEX:
PHIA) today announced its latest image guidance solutions to be
featured at Transcatheter Cardiovascular Therapeutics (TCT) in
Washington, D.C., October 29 – November 2,
2016. Philips will showcase the company's continued
commitment to addressing the needs of patients with the
introduction of instant wave-Free Ratio (iFR) co-registration,
which integrates iFR pullback data with the angiogram, and the
third generation of HeartNavigator, live image guidance software
for advanced structural heart disease procedures.
Philips Image Guided Therapy tools help clinicians decide, guide
and confirm the right therapy for delivery of better care to help
improve patient and economic outcomes. With iFR co-registration,
clinicians can assess coronary artery blockages by using the
Philips Volcano pressure measurement guidewires and equipment.
There is no need for time-consuming pullback devices or
guesswork.
Philips will also be introducing the third generation of its
innovative HeartNavigator planning and guidance software that
provides functionality to measure, select aortic valve repair
device, and choose the X-ray viewing angle. With HeartNavigator, a
3D volume is rendered from previously acquired CT datasets and
overlaid on live fluoro for real-time 3D guidance. The software
provides an immersive user experience, giving physicians more
confidence during challenging procedures, such as Transcatheter
Aortic Valve Replacement (TAVR).
In addition to Philips Image Guided Therapy tools, the Philips
booth (#1938) at TCT will also feature key integrated cardiology
solutions including ultrasound imaging and healthcare IT that
demonstrate the company's strategy across the health continuum,
from healthy living and prevention to diagnosis, treatment and home
care. Philips also will host several events and offer live
demonstrations, including iFR co-registration, at the Interactive
Technology Center to allow attendees to better understand the
clinical benefits of its offerings.
"Image-guided therapy is key to effective cardiovascular care,
and Philips is committed to offering innovative solutions that
enable more personalized care and better treatment for patients,"
said Bert van Meurs, Business Leader of Image Guided Therapy for
Philips. "The introduction of iFR co-registration adds to our
robust suite of integrated solutions and strategies for cardiology
that help healthcare professionals determine appropriate
therapeutic approaches and deliver treatment with more
confidence."
In addition to iFR co-registration and HeartNavigator, the
Philips booth at TCT will highlight the company's advanced
image-guidance technologies, delivering diagnostic confidence and
decision-making through every step of the cardiology patient
journey, including:
- IntelliSpace Cardiovascular – designed to help
streamline workflow and improve operational performance throughout
the cardiovascular care continuum
- EchoNavigator – fuses live TEE echo and live X-ray
imaging for guiding advanced SHD procedures in Cardiac Catheter and
Hybrid labs
- EPIQ7 Ultrasound System for Cardiology – features level
of clinical performance to meet the challenges of today's most
demanding cardiology practices
During TCT, Philips also will host several on-site events,
including:
- Lunch Symposium: The future of physiology – Exploring iFR
co-registration and ischemia-guided PCI (Monday, October 31, from 11:30 am – 12:30 pm
ET, Presentation Theater 2)
- Interactive Technology Center: Demonstration of iFR and IVUS
co-registration on SyncVision systems (Tuesday, November 1, from 9:00 am – 2:00 pm
ET, Hall A)
- Dinner Symposium: Controversies in PCI optimization – A
case-based discussion (Tuesday, November
1 from 6:00 pm – 8:00 pm ET, Independence Ballroom A-E)
For more information on Philips' presence at TCT 2016, please
visit the Philips TCT website, and follow the #TCT2016 conversation
with @PhilipsLiveFrom throughout the event.
About Royal Philips
Royal Philips (NYSE: PHG, AEX:
PHIA) is a leading health technology company focused on improving
people's health and enabling better outcomes across
the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to
deliver integrated solutions. The company is a leader in
diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as
in consumer health and home care.
Headquartered in the Netherlands,
Philips' health technology portfolio generated 2015 sales of
EUR 16.8 billion and employs
approximately 69,000 employees with sales and services in more than
100 countries. News about Philips can be found at
www.philips.com/newscenter.
Logo - http://photos.prnewswire.com/prnh/20150611/222617LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-showcases-its-latest-suite-of-image-guidance-solutions-for-the-minimally-invasive-treatment-of-cardiovascular-disease-at-tct-2016-300351354.html
SOURCE Royal Philips